Cargando…
RGD-hirudin-based low molecular weight peptide prevents blood coagulation via subcutaneous injection
Thromboembolic disease is a common cardio-cerebral vascular disease that threatens human life and health. Thrombin not only affects the exogenous coagulation pathway, but also the endogenous pathway. Thus, it becomes one of the most important targets of anticoagulant drugs. RGD-hirudin is an anticoa...
Autores principales: | Li, Ya-ran, Huang, Yi-nong, Zhao, Bing, Wu, Meng-fang, Li, Tian-yu, Zhang, Yan-ling, Chen, Di, Yu, Min, Mo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468311/ https://www.ncbi.nlm.nih.gov/pubmed/31949293 http://dx.doi.org/10.1038/s41401-019-0347-0 |
Ejemplares similares
-
Structural basis of RGD-hirudin binding to thrombin: Tyr(3) and five C-terminal residues are crucial for inhibiting thrombin activity
por: Huang, Yinong, et al.
Publicado: (2014) -
Expression, Purification, and Mass Spectrometric Analysis of (15)N, (13)C-Labeled RGD-Hirudin, Expressed in Pichia pastoris
, for NMR Studies
por: Huang, Yinong, et al.
Publicado: (2012) -
Self-regulated hirudin delivery for anticoagulant therapy
por: Xu, Xiao, et al.
Publicado: (2020) -
The hirudin-like factors HLF3 and HLF4—hidden hirudins of European medicinal leeches
por: Müller, Christian, et al.
Publicado: (2020) -
A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition
por: Mo, Wei, et al.
Publicado: (2008)